Apollo Hospitals Enterprise Limited
APOLLOHOSP
株式のランク
#1778
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
株価
$83.93
時価総額
$12.07B
変化（1日）
-1.23%
変化（1年）
-7.79%
国
IN
取引 Apollo Hospitals Enterprise Limited (APOLLOHOSP)
カテゴリー
Healthcare
Apollo Hospitals Enterprise Limited（APOLLOHOSP）の利益
Jun 2026 時点の利益 TTM: $317.50M
Apollo Hospitals Enterprise Limited の最新の財務報告によると、同社の現在の利益は $317.50M です。2024 年には $165.56M の利益を上げ、これは 2023 年の利益 $133.91M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Apollo Hospitals Enterprise Limited の利益の推移（2005 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $317.50M | 33.17% |
| 2025 | $238.42M | 44.01% |
| 2024 | $165.56M | 23.63% |
| 2023 | $133.91M | -35.88% |
| 2022 | $208.85M | 590.24% |
| 2021 | $30.26M | -65.30% |
| 2020 | $87.21M | 62.14% |
| 2019 | $53.79M | 104.25% |
| 2018 | $26.33M | -23.10% |
| 2017 | $34.25M | -31.69% |
| 2016 | $50.13M | -32.69% |
| 2015 | $74.48M | -3.94% |
| 2014 | $77.54M | 3.33% |
| 2013 | $75.04M | 16.73% |
| 2012 | $64.29M | 9.63% |
| 2011 | $58.64M | 33.25% |
| 2010 | $44.01M | 66.26% |
| 2009 | $26.47M | -10.97% |
| 2008 | $29.73M | 5.27% |
| 2007 | $28.24M | 86.81% |
| 2006 | $15.12M | 25.12% |
| 2005 | $12.08M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $9.87B | 3,008.95% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 1,117.31% |
US
|
|
| $687.82M | 116.63% |
SA
|
|
| $1.25B | 292.66% |
BR
|
